endovascular.es

Título: Medtronic Announces Beacon Heart Failure Management Service, Furthering Its Commitment to Delivering Value in Healthcare
Fecha: 28-06-2016
DUBLIN - June 28, 2016 - Medtronic plc (NYSE:MDT) today announced availability of its Beacon Heart Failure Management Service in the United States. This new service from Medtronic Care Management Services (MCMS) combines data from Medtronic implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT) devices with post-acute monitoring from MCMS, enabling providers to focus on heart failure patients with the greatest risk and evaluate early intervention before a heart failure event occurs.
"Beacon is a significant advance in our heart failure management arsenal," said Dr. Jawwad Yusuf, cardiologist, Advanced Heart Failure and Cardiac Transplantation, at The Stern Cardiovascular Foundation. "With its combination of valuable device diagnostics, day-to-day patient status and symptoms, and expert oversight of a trained care manager, Beacon allows clinicians to better identify, evaluate, and potentially intervene with their high-risk heart failure patients."
Beacon integrates device diagnostics, expert analysis, and proprietary remote monitoring solutions from MCMS to generate an enhanced picture of a patient's health. Patients using Beacon engage in daily health checks, which not only educate patients about their condition and self-care, but collect symptoms and biometrics through a series of branching-logic questions. This data is assembled alongside diagnostics from the patient's ICD or CRT device and reviewed by appropriately certified Medtronic care managers. Medtronic care managers follow established clinical pathways to review incoming data, monitor for information that could indicate a growing risk of a heart failure event and alert providers accordingly. Providers also receive monthly reports summarizing the patient's health information.
"Healthcare systems are under increasing pressure to improve patient care while also driving down associated cost. MCMS is committed to helping our customers deliver better patient outcomes while addressing these challenges," said Sheri Dodd, vice president and general manager, Medtronic Care Management Services. "Our technologies - and the data and insights they generate - put us in a unique position to help our customers enhance their patient care. With its combination of implanted device diagnostics, daily monitoring, and qualified expertise, Beacon is just one way Medtronic is innovating to provide clinically-meaningful services to hospitals, physicians, patients, and payers."
About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 85,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
-end-

Contacts:
Rebecca Metcalf
Public Relations
+1-763-526-9250

Ryan Weispfenning
Investor Relations
+1-763-505-4626
Fuente: endovascular.es

endovasculares.es